Fei Xavier Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fei Xavier Chen has a total of 342 co-authors. Here are the top co-authors by number of shared publications:
Aixia Song
13 shared publications- Yanhui Xu
Fudan University Shanghai Cancer Center, Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, Shanghai, China
10 shared publications Zhenning Wang
9 shared publications- Ali Shilatifard
Simpson Querrey Center for Epigenetics, Northwestern University Feinberg School of Medicine
8 shared publications Bolin Tao
8 shared publications- Aixia Song
Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, Shanghai Key Laboratory of Radiation Oncology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China
7 shared publications
Latest Publications
- Open Access
- 11 August 2026
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (19)
Corrigendum to An inherited predisposition allele promotes gastric cancer via enhancing deubiquitination-mediated activation of epithelial-to-mesenchymal transition signaling
- 11 August 2026
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (19)
Open AccessCorrigendum to An inherited predisposition allele promotes gastric cancer via enhancing deubiquitination-mediated activation of epithelial-to-mesenchymal transition signaling
- 10 August 2026
- Published by Springer Nature in Nature Reviews Molecular Cell Biology
- p. 1-22
Mechanisms of transcription termination across the coding and noncoding loci of the genome
- 10 August 2026
- Published by Springer Nature in Nature Reviews Molecular Cell Biology
- p. 1-22
Mechanisms of transcription termination across the coding and noncoding loci of the genome
- Open Access
- 17 April 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (4) , 117253
NSUN2-mediated GATM m5C methylation regulates creatine metabolism to drive mitochondrial fission and promote renal fibrosis
- 17 April 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (4) , 117253
Open AccessNSUN2-mediated GATM m5C methylation regulates creatine metabolism to drive mitochondrial fission and promote renal fibrosis
- 16 March 2026
- Published by Elsevier in Cell Stem Cell
- Vol. 33 (4) , 622-641.e11
Paired patient-derived organoids reveal transcription factor-driven epigenetic remodeling in breast cancer metastasis
- 16 March 2026
- Published by Elsevier in Cell Stem Cell
- Vol. 33 (4) , 622-641.e11
Paired patient-derived organoids reveal transcription factor-driven epigenetic remodeling in breast cancer metastasis
- 26 February 2026
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 33 (5) , 838-852
Integrator subunit INTS12 links ribotoxic stress to transcription-coupled nucleotide excision repair
Cells use transcription-coupled nucleotide excision repair (TC-NER) to efficiently resolve transcription-blocking DNA lesions caused by genotoxic stress such as ultraviolet (UV) irradiation. However, UV also induces RNA damage, triggering a cytoplasmic ribotoxic stress response (RSR). Whether and how RSR affects nuclear TC-NER has remained unclear. Here we identify INTS12, a flexible, poorly characterized subunit of the Integrator complex, as a key mediator linking RSR to TC-NER. Specifically, RSR-activated ZAK signaling induces phosphorylation of INTS12, enhancing its interaction with CSB and promoting recruitment of the Integrator complex to lesion-stalled RNA polymerase II (Pol II). This facilitates Pol II clearance and enables efficient DNA repair through TC-NER. Disruption of this pathway compromises TC-NER and transcription recovery, thereby increasing cellular sensitivity to UV-induced damage. Notably, the requirement for INTS12-mediated Pol II removal is context dependent, as it is not advantageous during the transcription-coupled response to formaldehyde-induced DNA–protein crosslinks, which rely on a distinct proteasome-dependent degradation pathway. Together, these findings uncover a regulatory axis connecting RNA damage signaling to DNA repair and highlight a context-dependent role of INTS12 in maintaining genome integrity.
- 26 February 2026
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 33 (5) , 838-852
Integrator subunit INTS12 links ribotoxic stress to transcription-coupled nucleotide excision repair
Cells use transcription-coupled nucleotide excision repair (TC-NER) to efficiently resolve transcription-blocking DNA lesions caused by genotoxic stress such as ultraviolet (UV) irradiation. However, UV also induces RNA damage, triggering a cytoplasmic ribotoxic stress response (RSR). Whether and how RSR affects nuclear TC-NER has remained unclear. Here we identify INTS12, a flexible, poorly characterized subunit of the Integrator complex, as a key mediator linking RSR to TC-NER. Specifically, RSR-activated ZAK signaling induces phosphorylation of INTS12, enhancing its interaction with CSB and promoting recruitment of the Integrator complex to lesion-stalled RNA polymerase II (Pol II). This facilitates Pol II clearance and enables efficient DNA repair through TC-NER. Disruption of this pathway compromises TC-NER and transcription recovery, thereby increasing cellular sensitivity to UV-induced damage. Notably, the requirement for INTS12-mediated Pol II removal is context dependent, as it is not advantageous during the transcription-coupled response to formaldehyde-induced DNA–protein crosslinks, which rely on a distinct proteasome-dependent degradation pathway. Together, these findings uncover a regulatory axis connecting RNA damage signaling to DNA repair and highlight a context-dependent role of INTS12 in maintaining genome integrity.
- 10 October 2025
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 50 (12) , 1118-1130
The Integrator–PP2A complex integrates promoter-proximal premature termination with chromatin context and genome maintenance
- 10 October 2025
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 50 (12) , 1118-1130
The Integrator–PP2A complex integrates promoter-proximal premature termination with chromatin context and genome maintenance
- Open Access
- 5 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
DSS1 is required for proper Integrator–PP2A function
Integrator–PP2A (INTAC) is a highly modular complex orchestrating the transition of paused RNA polymerase II into productive elongation or promoter-proximal premature termination, with its loss resulting in transcription dysregulation and genome instability. Here, we identify human DSS1—a flexible 70-residue protein found in multiple functionally diverse complexes including the 26S proteasome—as an integral subunit of the INTAC backbone. Structural analysis of DSS1–INTAC, both alone and in association with paused polymerase, demonstrates intimate interactions between DSS1 and the INTAC backbone. We identify tryptophan 39 of DSS1 as being critical for interacting with INTAC and find that its mutation disrupts DSS1’s interaction with INTAC, while maintaining DSS1’s interaction with the proteasome. This substitution not only impairs INTAC-dependent transcriptional regulation, but also reveals that INTAC is DSS1’s major chromatin-bound form. Together, our findings reveal a role for DSS1 in supporting the structure and regulatory functions of INTAC.
- 5 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open AccessDSS1 is required for proper Integrator–PP2A function
Integrator–PP2A (INTAC) is a highly modular complex orchestrating the transition of paused RNA polymerase II into productive elongation or promoter-proximal premature termination, with its loss resulting in transcription dysregulation and genome instability. Here, we identify human DSS1—a flexible 70-residue protein found in multiple functionally diverse complexes including the 26S proteasome—as an integral subunit of the INTAC backbone. Structural analysis of DSS1–INTAC, both alone and in association with paused polymerase, demonstrates intimate interactions between DSS1 and the INTAC backbone. We identify tryptophan 39 of DSS1 as being critical for interacting with INTAC and find that its mutation disrupts DSS1’s interaction with INTAC, while maintaining DSS1’s interaction with the proteasome. This substitution not only impairs INTAC-dependent transcriptional regulation, but also reveals that INTAC is DSS1’s major chromatin-bound form. Together, our findings reveal a role for DSS1 in supporting the structure and regulatory functions of INTAC.
- Open Access
- 4 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (27) , eadt8765
H3K79 methylation and H3K36 trimethylation synergistically regulate gene expression in pluripotent stem cells
Metazoan nucleosomes harboring H3K79 methylation (H3K79me) deposited by the methyltransferase DOT1L (disruptor of telomeric silencing 1-like) decorate actively transcribed genes. While DOT1L regulates transcription and the pathogenesis of leukemia and neurological disorders, the role of H3K79me remains elusive. Here, we reveal a functional synergism between H3K79me and H3K36 trimethylation (H3K36me3) in regulating gene expression and cellular differentiation. Simultaneous catalytic inactivation of DOT1L and the H3K36 methyltransferase SETD2 (SET domain containing 2) leads to hyperactive transcription and failures in neural differentiation. H3K79me/H3K36me3 loss causes increased transcription elongation, gained chromatin accessibility at a group of enhancers, and increased recruitment of TEAD4 (TEA domain transcription factor 4) and its coactivator YAP1 (Yes-associated protein 1) to these enhancers. Furthermore, YAP-TEAD inhibition restores the expression levels of genes hyperactivated by H3K79me/H3K36me3 loss. Together, we demonstrate a synergism of H3K79me and H3K36me3 in regulating transcription and cell fate transition, unveil the underlying mechanisms, and provide insight into targeting diseases driven by misregulation/mutations of DOT1L and/or SETD2.
- 4 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (27) , eadt8765
Open AccessH3K79 methylation and H3K36 trimethylation synergistically regulate gene expression in pluripotent stem cells
Metazoan nucleosomes harboring H3K79 methylation (H3K79me) deposited by the methyltransferase DOT1L (disruptor of telomeric silencing 1-like) decorate actively transcribed genes. While DOT1L regulates transcription and the pathogenesis of leukemia and neurological disorders, the role of H3K79me remains elusive. Here, we reveal a functional synergism between H3K79me and H3K36 trimethylation (H3K36me3) in regulating gene expression and cellular differentiation. Simultaneous catalytic inactivation of DOT1L and the H3K36 methyltransferase SETD2 (SET domain containing 2) leads to hyperactive transcription and failures in neural differentiation. H3K79me/H3K36me3 loss causes increased transcription elongation, gained chromatin accessibility at a group of enhancers, and increased recruitment of TEAD4 (TEA domain transcription factor 4) and its coactivator YAP1 (Yes-associated protein 1) to these enhancers. Furthermore, YAP-TEAD inhibition restores the expression levels of genes hyperactivated by H3K79me/H3K36me3 loss. Together, we demonstrate a synergism of H3K79me and H3K36me3 in regulating transcription and cell fate transition, unveil the underlying mechanisms, and provide insight into targeting diseases driven by misregulation/mutations of DOT1L and/or SETD2.
- Open Access
- 27 April 2025
- Published by Science China Press., Co. Ltd. in Chinese Science Bulletin
- Vol. 70 (15) , 2385-2396
Recent progress in understanding the functions and mechanisms of the INTAC complex
基因表达的精确时空调控对生物体的生存和发育至关重要。作为一种后生动物特异性的多亚基复合物,能够与蛋白磷酸酶PP2A核心酶(PP2A-AC)形成稳定的复合体,被命名为INTAC(–PP2A-AC)。INTAC复合体是RNA聚合酶Ⅱ启动子近端暂停和提前终止的关键调节因子,还对多种非编码RNA进行3’末端加工。INTAC复合体在转录调控中发挥重要作用,其功能缺失与多种生理过程异常及疾病发生密切相关。本文系统梳理了INTAC复合体的发现历程、结构特征及功能进展,重点解析了其在转录调控过程中的多重作用,并总结了INTAC复合体在生理和疾病中的关键功能。
- 27 April 2025
- Published by Science China Press., Co. Ltd. in Chinese Science Bulletin
- Vol. 70 (15) , 2385-2396
Open AccessRecent progress in understanding the functions and mechanisms of the INTAC complex
基因表达的精确时空调控对生物体的生存和发育至关重要。作为一种后生动物特异性的多亚基复合物,能够与蛋白磷酸酶PP2A核心酶(PP2A-AC)形成稳定的复合体,被命名为INTAC(–PP2A-AC)。INTAC复合体是RNA聚合酶Ⅱ启动子近端暂停和提前终止的关键调节因子,还对多种非编码RNA进行3’末端加工。INTAC复合体在转录调控中发挥重要作用,其功能缺失与多种生理过程异常及疾病发生密切相关。本文系统梳理了INTAC复合体的发现历程、结构特征及功能进展,重点解析了其在转录调控过程中的多重作用,并总结了INTAC复合体在生理和疾病中的关键功能。
- 18 March 2025
- Published by Springer Nature in Nature Cancer
- Vol. 6 (4) , 629-646
Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer
The transdifferentiation from adenocarcinoma to neuroendocrine prostate cancer (NEPC) in men confers antiandrogen therapy resistance. Here our analysis combining CRISPR‒Cas9 screening with single-cell RNA sequencing tracking of tumor transition demonstrated that antiandrogen-induced zinc finger MYND-type containing 8 (ZMYND8)-dependent epigenetic programming orchestrates NEPC transdifferentiation. Ablation of Zmynd8 prevents NEPC development, while ZMYND8 upregulation mediated by achaete-scute homolog 1 promotes NEPC differentiation. We show that forkhead box protein M1 (FOXM1) stabilizes ZMYND8 binding to chromatin regions characterized by H3K4me1–H3K14ac modification and FOXM1 targeting. Antiandrogen therapy releases the SWI/SNF chromatin remodeling complex from the androgen receptor, facilitating its interaction with ZMYND8–FOXM1 to upregulate critical neuroendocrine lineage regulators. We develop iZMYND8-34, a small molecule designed to inhibit ZMYND8’s histone recognition, which effectively blocks NEPC development. These findings reveal the critical role of ZMYND8-dependent epigenetic programming induced by androgen deprivation therapy in orchestrating lineage fate. Targeting ZMYND8 emerges as a promising strategy for impeding NEPC development.
- 18 March 2025
- Published by Springer Nature in Nature Cancer
- Vol. 6 (4) , 629-646
Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer
The transdifferentiation from adenocarcinoma to neuroendocrine prostate cancer (NEPC) in men confers antiandrogen therapy resistance. Here our analysis combining CRISPR‒Cas9 screening with single-cell RNA sequencing tracking of tumor transition demonstrated that antiandrogen-induced zinc finger MYND-type containing 8 (ZMYND8)-dependent epigenetic programming orchestrates NEPC transdifferentiation. Ablation of Zmynd8 prevents NEPC development, while ZMYND8 upregulation mediated by achaete-scute homolog 1 promotes NEPC differentiation. We show that forkhead box protein M1 (FOXM1) stabilizes ZMYND8 binding to chromatin regions characterized by H3K4me1–H3K14ac modification and FOXM1 targeting. Antiandrogen therapy releases the SWI/SNF chromatin remodeling complex from the androgen receptor, facilitating its interaction with ZMYND8–FOXM1 to upregulate critical neuroendocrine lineage regulators. We develop iZMYND8-34, a small molecule designed to inhibit ZMYND8’s histone recognition, which effectively blocks NEPC development. These findings reveal the critical role of ZMYND8-dependent epigenetic programming induced by androgen deprivation therapy in orchestrating lineage fate. Targeting ZMYND8 emerges as a promising strategy for impeding NEPC development.